UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017734
Receipt number R000020534
Scientific Title A clinical trial for the validation of safety and efficacy of the implant-type tissue-engineered cartilage using autologous cells.
Date of disclosure of the study information 2015/06/18
Last modified on 2020/06/17 10:43:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A clinical trial for the validation of safety and efficacy of the implant-type tissue-engineered cartilage using autologous cells.

Acronym

A clinical trial of the implant-type tissue-engineered cartilage using autologous cells.

Scientific Title

A clinical trial for the validation of safety and efficacy of the implant-type tissue-engineered cartilage using autologous cells.

Scientific Title:Acronym

A clinical trial of the implant-type tissue-engineered cartilage using autologous cells.

Region

Japan


Condition

Condition

Severe nasal deformity in orofacial cleft, that needs nasal augmentation and nasal tip correction

Classification by specialty

Oral surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Safety, and collaterally, efficacy of FSI 2007, the implant-type tissue-engineered cartilage using autologous cells, are to be validated by applying it to patients of orofacial cleft with nasal deformities.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Occurrence and details of all adverse events, those related to the investigative product, and defect of the product are evaluated to validate safety.

Key secondary outcomes

Indices such as the distance from nasal tip to nasal root, the area of nose, evaluation of the appearance of whole face and nose/mouth, cosmetic satisfaction, change in daily activity, change in depressiveness, evaluation of the cartilage collection site, evaluation of nasal curvature, evaluation of hardness of the transplantation site, and evaluation of fixing and cartilage maturation by MRI are used exploratory to evaluate the efficacy.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Transplantation of the implant-type tissue-engineered cartilage using autologous cells

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients meeting all of criteria below will be included.
1. Patients with nasal deformities in orofacial cleft, that needs nasal augmentation and nasal tip correction
2. Patients who can keep the schedule of observation and investigation described in the protocol of this clinical trial.
3. Patients of age 20 or older (on obtainment of informed consent)
4. Patients who can understand the content of this clinical trial and agree to the written informed consent.

Key exclusion criteria

Patients who meet any of the following criteria are excluded.
1. Patients from whom sufficient blood cannot be collected (e.g. by recent blood donation).
2. ASA physical status 3 or worse.
3. Existing or possible malignancy.
4. Uncontrolled diabetes.
5. Possible sepsis.
6. Recurrent skin infection at the surgical sites, e.g. ears or noses.
7. Patients who received, or will undergo surgeries at the operative sites within 1 year before surgery in this trial.
8. Females with existing or possible pregnancy, lactating, or who cannot agree with anticonception until 6 months after the transplantation of FSI2007.
9. Patients found positive in allergy test for atelocollagen
10. Possible syphilis, B/C hepatitis, HIV infection or adult T cell lymphoma.
11. Present, past or family histories of autoimmune diseases, e.g. rheumatoid arthritis, psoriatic arthritis, systemic/discoid lupus erythematosus, dermatomyositis, polymyositis, chronic thyroiditis, Graves' disease, polyartritis, scleroderma, ulcerous colitis, Crohn's disease, Sjogren's syndrome, Reiter syndrome, mixed connective tissue disease or relapsing polychondritis.
12. Histories of anaphylaxia.
13. Histories or possibilities of hypersensitivity or allergy to collagen products, lactic acid polymer, fibroblast growth factor (FGF), insulin, penicillin or streptomycin.
14. Patients who used or will use FGF-2, parathyroid hormone, insulin-like growth factor-I, insulin, growth hormone, female hormones (except cosmetics), male hormones, interleukin-1 receptor antagonist, thyroid hormone, vitamin D (except supplements) or steroids (except topical products) 3 months before blood collection.
15. Patients who were in other clinical trials or clinical researches within 30 days before the obtainment of the consent.
16. Patients with mental diseases who cannot fill out survey slips.
17. Patients judged to be inappropriate as subjects of this trial by the responsive doctor or assigned doctors.

Target sample size

2


Research contact person

Name of lead principal investigator

1st name Kazuto
Middle name
Last name Hoshi

Organization

The University of Tokyo Hospital

Division name

The Department of Oral-Maxillofacial Surgery and Orthodontics

Zip code

113-8655

Address

7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655 JAPAN

TEL

03-3815-5411

Email

pochi-tky@umin.ac.jp


Public contact

Name of contact person

1st name Kazuto
Middle name
Last name Hoshi

Organization

The University of Tokyo Hospital

Division name

The Department of Oral-Maxillofacial Surgery and Orthodontics

Zip code

113-8655

Address

7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655 JAPAN

TEL

03-3815-5411

Homepage URL


Email

pochi-tky@umin.net


Sponsor or person

Institute

The University of Tokyo Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board, the University of Tokyo Hospital

Address

7-3-1 Hongo, Bunkyo-ku, Tokyo

Tel

03-5800-8743

Email

crctky-office@umin.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京大学医学部附属病院(東京都)


Other administrative information

Date of disclosure of the study information

2015 Year 06 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

2

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

The application for approval is in progress.

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 03 Month 23 Day

Date of IRB

2015 Year 03 Month 19 Day

Anticipated trial start date

2015 Year 06 Month 18 Day

Last follow-up date

2019 Year 03 Month 26 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 05 Month 29 Day

Last modified on

2020 Year 06 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020534


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name